Flex Pharma raises $40 mln from big investor group

Flex Pharma, a biopharmaceutical company focused on treatments for neuromuscular disorders, has raised $40 million from an investor group. Investors include Longwood Fund, Bessemer Venture Partners, EcoR1 Capital, Jennison Associates, Lightstone Ventures, Alexandria Equities, CD-Venture, Bindley Capital Partners, City Hill Ventures and several individuals including Steve Pagliuca, managing director at Bain Capital.


TCV hires Bain executive to lead investor relations

Technology Crossover Ventures has hired Bain Capital executive Nathan Sanders as a general partner and head of investor relations. In the role, Sanders will work with TCV’s limited partners and lead the firm’s fundraising. Sanders worked at Bain for eight years as a director, focusing on deals and portfolio companies and working on investor relations.


peHUB First Read

To guide you through this Friday the 13th, First Read has news that Bain Capital Partners is suing EY, the Supreme Court wants companies to be more truthful about food labeling and we may be heading for higher prices at the pump as Iraq falls apart.

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget